SCHEMBL5660432

SCHEMBL5660432

COc1cccc(N2C(=O)C(c3cc(C)c(O)c(C)c3)(c3cc(C)c(N)c(Cl)c3)c3ccccc32)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.38
MAPT P10636 5/20 0.37
TP53 P04637 2/20 0.36
MGLL Q99685 1/20 0.36
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CBX7 O95931 1/20 0.33
CDYL2 Q8N8U2 1/20 0.33
CDYL Q9Y232 1/20 0.33
CDY1; CDY1B Q9Y6F8 1/20 0.33
EDNRB P24530 1/20 0.33
EDNRA P25101 1/20 0.33
NPBWR1 P48145 1/20 0.33
MCHR1 Q99705 1/20 0.33
NR1H3 Q13133 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5658916 0.93 MAPT (0.40) SCN9AMAPTMGLLALDH1A1KDM4E
SCHEMBL5656443 0.90 MAPT (0.44) SCN9AMAPTMGLLALDH1A1KDM4E
SCHEMBL5662112 0.87 MAPT (0.41) SCN9AMAPTTP53MGLLALDH1A1
SCHEMBL5660840 0.87 MAPT (0.38) SCN9AMAPTMGLLALDH1A1KDM4E
SCHEMBL5661100 0.86 MAPT (0.41) SCN9AMAPTTP53MGLLALDH1A1
SCHEMBL5656731 0.86 MAPT (0.41) SCN9AMAPTTP53MGLLALDH1A1
SCHEMBL5658510 0.85 CNR1 (0.46) SCN9AMAPTMGLLALDH1A1KDM4E
SCHEMBL5659434 0.85 MAPT (0.42) SCN9AMAPTTP53MGLLALDH1A1
SCHEMBL5661921 0.84 MAPT (0.41) SCN9AMAPTTP53MGLLALDH1A1
SCHEMBL5658260 0.83 ALDH1A1 (0.40) SCN9AMAPTTP53MGLLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 SCN9A 1918/4885MAPT 3588/4885TP53 3370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.